Deutsche Bank Initiates Agilent Technologies (A) at Buy
Key Points
- Deutsche Bank's new target of $190 is about 9.8% above Agilent's recent trading price of $173.07.
- Deutsche Bank's $190 price target implies 9.78% upside from Agilent Technologies, Inc.'s ($A) current $173.07 share price.
- The stock closed at $175.76 on October 26, 2026, which is about 1.5% below its recent price.
- Agilent Technologies has a market cap of approximately $48.8 billion and reported a revenue growth of 8.1% year-over-year.
Get Agilent Technologies text alerts
We text you when insiders, Congress, analysts or big funds move on $A.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Agilent Technologies, Inc. alert may contain errors. Disclosures
On October 26, 2026, Deutsche Bank reiterated its Buy rating on Agilent Technologies, Inc. (NYSE: A) and set a price target of $190. This move reflects Deutsche Bank's confidence in Agilent's future performance, especially as the stock trades below this target.
Deutsche Bank's new price target is about 9.8% above Agilent's recent trading price of $173.07. The stock closed at $175.76 on the same day, indicating it was about 1.5% below its recent price. Agilent's stock has been performing well, trading above both its 50-day and 200-day moving averages, which suggests a positive trend in the stock's performance.
Deutsche Bank vs. the S&P 500
Hypothetical returns from Deutsche Bank's disclosed trades, not real profit or advice. How we model this.
Other Institutional Activity in Agilent Technologies
Massachusetts Financial Services Co. reduced its holdings by 2,613,177 shares, ending with 10,010,867 shares valued at approximately $1.76 billion. Deutsche Bank AG grew its stake by 1,024,486 shares, bringing its total to 7,008,634 shares worth about $1.23 billion. Bank Of New York Mellon Corporation increased its holdings by 2,440,431 shares, resulting in a total of 5,233,964 shares valued at around $919.9 million.
Agilent Technologies, Inc. Stock Down 0.5%
Agilent Technologies recently traded at $173.07, which is below its closing price of $175.76 on October 26, 2026. The stock remains below its 52-week high of $179.10 but is significantly above its 52-week low of $108.35, suggesting it has maintained a strong performance over the past year.
$A price target
Agilent Technologies, Inc. daily closes and this analyst's $190 target. Not advice.
Recent Earnings
Agilent reported trailing twelve-month revenue of approximately $7.37 billion, reflecting an 8.1% year-over-year revenue growth. The company's net margin stands at 19.5%, and it has a return on equity of 21.0%. The next earnings report is expected on November 25, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
5 target cuts vs 1 raises.
-
EPS & revenue
EPS beat estimates by 3.8%. Revenue met estimates.
-
Profit surprise
EBITDA missed by 4 percent. Operating income missed by 7 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
1 upgrade, 1 target raise, 5 target cuts.
-
Earnings quality
Gross margin up 3.1 points. Operating margin up 3.8 points. Positive free cash flow.
Earnings Call Summary
Agilent delivered a strong second quarter with $1.83 billion in revenue, up 6.3 percent core growth and beating guidance by 80 basis points. Earnings per share came in at $1.49, beating expectations by 7 cents and growing 14 percent year over year. Operating margin expanded 130 basis points to 26.4 percent, well ahead of guidance. The company is seeing robust momentum across its instrument business with double digit growth in LC LCMS and GC driven by replacement cycles and share gains. Diagnostics grew 11 percent led by the Omnis family and cancer offerings. Strategic pricing delivered over 200 basis points of contribution, exceeding the annual target of 100 basis points at midyear. Management credited the Ignite operating system for driving execution excellence and structural improvements.
Guidance Management raised full year revenue and earnings guidance. The company now expects $7.39 to $7.49 billion in annual revenue with core growth of 4.5 to 6.0 percent, up 30 basis points from prior guidance. Earnings per share guidance increased to $6.00 to $6.10, up 8 cents at the midpoint. For the third quarter, they forecast $1.83 to $1.85 billion in revenue with EPS of $1.48 to $1.50.
Clearly negative report. The company missed important expectations and likely triggers downward revisions.
Analysts Set New Price Targets
On October 26, 2026, Deutsche Bank initiated coverage with a Buy rating and a price target of $190. Other analysts have also maintained positive views, with Wells Fargo setting a target at $180, Barclays at $195, and TD Cowen at $196, all before this date.
About Agilent Technologies
Agilent Technologies, Inc. provides specialized solutions in the life sciences, diagnostics, and applied chemical markets. With a focus on innovation, Agilent operates through three main segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. This diverse focus helps the company maintain a strong position in the healthcare sector.
Bottom Line
Agilent Technologies continues to attract positive attention from analysts, with Deutsche Bank's recent reiteration of a Buy rating and a target of $190. Investors should watch for the upcoming earnings report on November 25, 2026, for further insights into the company’s performance.
Source: Deutsche Bank's rating change on $A (Oct 26, 2026). Written by software, not financial advice. How we make alerts